Blood Purification Systems

SARS-CoV-2 infections develop into serious disease in about 13.8% of cases and critical disease in 6.1%. Patients may develop sepsis, acute respiratory distress syndrome and/or multi-organ failure. This has prompted researchers to look at alternative methods to treat critically ill COVID-19 patients, including administration of convalescent plasma, plasma transfusion and blood purification. Plasma transfusion and blood purification therapies are aimed at treating the systemic response. Learn more by accessing this document.

Please Register or Login

You must be logged in to access exclusive content within our clinical resources.

Register Log-in